ED
39
3
PG
43
3
YUM
56
2
DD
55
-4
BA
42
4
QRVO
48
-5
C
79
-2
RSG
51
3
PX
60
-3
RIG
43
-7
VRSN
42
-2
LYB
23
-4
XYL
41
-8
SHW
53
-2
HPE
64
-5
WMB
48
-4
TEL
74
-14
CMI
72
-5
DHR
66
-4
PNR
66
-2
ED
39
3
PG
43
3
YUM
56
2
DD
55
-4
BA
42
4
QRVO
48
-5
C
79
-2
RSG
51
3
PX
60
-3
RIG
43
-7
VRSN
42
-2
LYB
23
-4
XYL
41
-8
SHW
53
-2
HPE
64
-5
WMB
48
-4
TEL
74
-14
CMI
72
-5
DHR
66
-4
PNR
66
-2
Financhill
Back

KEYENCE Corp. Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison

Sell
49

KYCCF
KEYENCE Corp.

Last Price:
$355.00
Seasonality Move:
3.13%
Sell
48

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$36.24
Seasonality Move:
6.21%
Sell
49
KEYENCE Corp. (KYCCF) is a Sell

Is KEYENCE Corp. a Buy, Sell or Hold?

  • The current KEYENCE Corp. [KYCCF] share price is $355.00. The Score for KYCCF is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • KYCCF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $36.23. The Score for RARE is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KYCCF Stock Price Chart

What is KEYENCE Corp.'s stock price today?

  • The KEYENCE Corp. share price today is $355.00
    The current trend is relatively stagnant and KYCCF is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

  • The Ultragenyx Pharmaceutical, Inc. share price today is $36.23
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight selling pressure.

KYCCF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.26 Sell
Relative Strength Index (14 RSI): 50.54 Buy
Chaikin Money Flow: -4907 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (339.4 - 357.12) Buy
Bollinger Bands (100): (357.03 - 395.91) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.99 Buy
Relative Strength Index (14 RSI): 61.17 Buy
Chaikin Money Flow: -31475 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.18 - 35.78) Buy
Bollinger Bands (100): (28.77 - 33.95) Buy

KYCCF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 349.09 Buy
20-day SMA: 345.78 Buy
50-day SMA: 370.51 Sell
200-day SMA: 390.56 Sell
8-day EMA: 350.37 Buy
20-day EMA: 351.2 Buy
50-day EMA: 362.72 Sell
200-day EMA: 388.35 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.32 Sell
20-day SMA: 34.36 Buy
50-day SMA: 33.41 Buy
200-day SMA: 33.75 Buy
8-day EMA: 35.88 Buy
20-day EMA: 34.85 Buy
50-day EMA: 33.54 Buy
200-day EMA: 34.8 Buy

KEYENCE Corp. Earnings Growth & KYCCF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

KEYENCE Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):